Compounds > 1-methyl-1,2,3,4-tetrahydroisoquinoline
Page last updated: 2024-08-26

1-methyl-1,2,3,4-tetrahydroisoquinoline and MPTP Neurotoxicity Syndrome

1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abe, K; Chiba, T; Ishikawa, R; Kambe, T; Munakata, H; Saitoh, T; Taguchi, K1

Other Studies

1 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and MPTP Neurotoxicity Syndrome

ArticleYear
Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
    Canadian journal of physiology and pharmacology, 2022, Jul-01, Volume: 100, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Humans; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Parkinsonian Disorders; Tetrahydroisoquinolines

2022